Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system

D. Milo-Landesman, M. Surana, I. Berkovich, A. Compagni, G. Christofori, N. Fleischer, S. Efrat

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Pancreatic β cell lines may offer an abundant source of cells for β-cell replacement in type I diabetes. Using regulatory elements of the bacterial tetracycline (tet) operon for conditional expression of SV40 T antigen oncoprotein in transgenic mouse β cells, we have shown that reversible immortalization is an efficient approach for regulated β-cell expansion, accompanied by enhanced cell differentiation upon growth arrest. The original system employed the tet-off approach, in which the cells proliferate in the absence of tet ligands and undergo growth arrest in their presence. The disadvantage of this system is the need for continuous treatment with the ligand in vivo for maintaining growth arrest. Here we utilized the tet-on regulatory system to generate β cell lines in which proliferation is regulated in reverse: these cells divide in the presence of tet ligands, and undergo growth arrest in their absence, as judged by [3H]thymidine and BrdU incorporation assays. These cell lines were derived from insulinomas, which heritably developed in transgenic mice continuously treated with the tet derivative doxycycline (dox). The cells produce and secrete high amounts of insulin, and can restore and maintain euglycemia in syngeneic streptozotocin-induced diabetic mice in the absence of dox. Such a system is more suitable for transplantation, compared with cells regulated by the tet-off approach, because ligand treatment is limited to cell expansion in culture and is not required for long-term maintenance of growth arrest in vivo.

Original languageEnglish (US)
Pages (from-to)645-650
Number of pages6
JournalCell Transplantation
Volume10
Issue number7
StatePublished - 2001

Fingerprint

Tetracycline
Hyperglycemia
Ligands
Cells
Growth
Doxycycline
Insulin
Cell Line
Antigens
Medical problems
Transgenic Mice
Assays
Polyomavirus Transforming Antigens
Insulinoma
Derivatives
Oncogene Proteins
Bromodeoxyuridine
Operon
Streptozocin
Type 1 Diabetes Mellitus

Keywords

  • β cell lines
  • Diabetes
  • Growth arrest
  • Insulin secretion
  • SV40 T antigen

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Milo-Landesman, D., Surana, M., Berkovich, I., Compagni, A., Christofori, G., Fleischer, N., & Efrat, S. (2001). Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system. Cell Transplantation, 10(7), 645-650.

Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system. / Milo-Landesman, D.; Surana, M.; Berkovich, I.; Compagni, A.; Christofori, G.; Fleischer, N.; Efrat, S.

In: Cell Transplantation, Vol. 10, No. 7, 2001, p. 645-650.

Research output: Contribution to journalArticle

Milo-Landesman, D, Surana, M, Berkovich, I, Compagni, A, Christofori, G, Fleischer, N & Efrat, S 2001, 'Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system', Cell Transplantation, vol. 10, no. 7, pp. 645-650.
Milo-Landesman, D. ; Surana, M. ; Berkovich, I. ; Compagni, A. ; Christofori, G. ; Fleischer, N. ; Efrat, S. / Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system. In: Cell Transplantation. 2001 ; Vol. 10, No. 7. pp. 645-650.
@article{be0622cff36b468f93d8772333ee9bb9,
title = "Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system",
abstract = "Pancreatic β cell lines may offer an abundant source of cells for β-cell replacement in type I diabetes. Using regulatory elements of the bacterial tetracycline (tet) operon for conditional expression of SV40 T antigen oncoprotein in transgenic mouse β cells, we have shown that reversible immortalization is an efficient approach for regulated β-cell expansion, accompanied by enhanced cell differentiation upon growth arrest. The original system employed the tet-off approach, in which the cells proliferate in the absence of tet ligands and undergo growth arrest in their presence. The disadvantage of this system is the need for continuous treatment with the ligand in vivo for maintaining growth arrest. Here we utilized the tet-on regulatory system to generate β cell lines in which proliferation is regulated in reverse: these cells divide in the presence of tet ligands, and undergo growth arrest in their absence, as judged by [3H]thymidine and BrdU incorporation assays. These cell lines were derived from insulinomas, which heritably developed in transgenic mice continuously treated with the tet derivative doxycycline (dox). The cells produce and secrete high amounts of insulin, and can restore and maintain euglycemia in syngeneic streptozotocin-induced diabetic mice in the absence of dox. Such a system is more suitable for transplantation, compared with cells regulated by the tet-off approach, because ligand treatment is limited to cell expansion in culture and is not required for long-term maintenance of growth arrest in vivo.",
keywords = "β cell lines, Diabetes, Growth arrest, Insulin secretion, SV40 T antigen",
author = "D. Milo-Landesman and M. Surana and I. Berkovich and A. Compagni and G. Christofori and N. Fleischer and S. Efrat",
year = "2001",
language = "English (US)",
volume = "10",
pages = "645--650",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "7",

}

TY - JOUR

T1 - Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic β cells controlled by the tet-on regulatory system

AU - Milo-Landesman, D.

AU - Surana, M.

AU - Berkovich, I.

AU - Compagni, A.

AU - Christofori, G.

AU - Fleischer, N.

AU - Efrat, S.

PY - 2001

Y1 - 2001

N2 - Pancreatic β cell lines may offer an abundant source of cells for β-cell replacement in type I diabetes. Using regulatory elements of the bacterial tetracycline (tet) operon for conditional expression of SV40 T antigen oncoprotein in transgenic mouse β cells, we have shown that reversible immortalization is an efficient approach for regulated β-cell expansion, accompanied by enhanced cell differentiation upon growth arrest. The original system employed the tet-off approach, in which the cells proliferate in the absence of tet ligands and undergo growth arrest in their presence. The disadvantage of this system is the need for continuous treatment with the ligand in vivo for maintaining growth arrest. Here we utilized the tet-on regulatory system to generate β cell lines in which proliferation is regulated in reverse: these cells divide in the presence of tet ligands, and undergo growth arrest in their absence, as judged by [3H]thymidine and BrdU incorporation assays. These cell lines were derived from insulinomas, which heritably developed in transgenic mice continuously treated with the tet derivative doxycycline (dox). The cells produce and secrete high amounts of insulin, and can restore and maintain euglycemia in syngeneic streptozotocin-induced diabetic mice in the absence of dox. Such a system is more suitable for transplantation, compared with cells regulated by the tet-off approach, because ligand treatment is limited to cell expansion in culture and is not required for long-term maintenance of growth arrest in vivo.

AB - Pancreatic β cell lines may offer an abundant source of cells for β-cell replacement in type I diabetes. Using regulatory elements of the bacterial tetracycline (tet) operon for conditional expression of SV40 T antigen oncoprotein in transgenic mouse β cells, we have shown that reversible immortalization is an efficient approach for regulated β-cell expansion, accompanied by enhanced cell differentiation upon growth arrest. The original system employed the tet-off approach, in which the cells proliferate in the absence of tet ligands and undergo growth arrest in their presence. The disadvantage of this system is the need for continuous treatment with the ligand in vivo for maintaining growth arrest. Here we utilized the tet-on regulatory system to generate β cell lines in which proliferation is regulated in reverse: these cells divide in the presence of tet ligands, and undergo growth arrest in their absence, as judged by [3H]thymidine and BrdU incorporation assays. These cell lines were derived from insulinomas, which heritably developed in transgenic mice continuously treated with the tet derivative doxycycline (dox). The cells produce and secrete high amounts of insulin, and can restore and maintain euglycemia in syngeneic streptozotocin-induced diabetic mice in the absence of dox. Such a system is more suitable for transplantation, compared with cells regulated by the tet-off approach, because ligand treatment is limited to cell expansion in culture and is not required for long-term maintenance of growth arrest in vivo.

KW - β cell lines

KW - Diabetes

KW - Growth arrest

KW - Insulin secretion

KW - SV40 T antigen

UR - http://www.scopus.com/inward/record.url?scp=0035574854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035574854&partnerID=8YFLogxK

M3 - Article

C2 - 11714200

AN - SCOPUS:0035574854

VL - 10

SP - 645

EP - 650

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 7

ER -